ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 185 filers reported holding ASCENDIS PHARMA A/S in Q3 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.8%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 4,240,536 | $300,484,000 | 16.06% |
Sofinnova Investments, Inc. | 2,479,514 | $175,698,000 | 15.66% |
Vivo Capital, LLC | 2,166,832 | $153,542,000 | 15.48% |
VHCP Management II, LLC | 504,210 | $35,728,000 | 9.54% |
EcoR1 Capital, LLC | 1,087,257 | $77,043,000 | 6.94% |
Avoro Capital Advisors LLC | 1,963,336 | $139,122,000 | 6.39% |
Foresite Capital Management IV, LLC | 245,424 | $17,391,000 | 5.70% |
Eventide Asset Management | 1,544,900 | $109,472,000 | 4.02% |
Orbimed Advisors | 4,155,891 | $294,486,000 | 3.55% |
Ghost Tree Capital, LLC | 225,000 | $15,944,000 | 3.39% |